CoreAge Rx and PeterMD provide different starting points for a sermorelin conversation. CoreAge advertises a monthly starting rate, while PeterMD's published offer is best summarized as: $211.65 / 4-week supply. This comparison keeps the conditions beside the numbers rather than treating them as equivalent treatment plans.
CoreAge Rx is our featured commercial partner and appears first through that arrangement. This is a comparison of public service information, not a clinical trial or a finding that one provider produces better outcomes. We have not purchased care from either service or audited its dispensing pharmacies.
Compare CoreAge Rx and PeterMD on the complete charge, assessment, pharmacy, and follow-up. CoreAge has disclosed commercial first placement.
CoreAge Rx: the starting offer
The CoreAge Rx product page advertises from $99/month. Advertised starting rate; confirm prepayment, supply, and renewal. Its published offer describes no separate membership fee and free delivery. Those descriptions do not establish a particular patient's checkout amount or whether every clinical service is included.
Ask which plan applies to the proposed prescription and whether the displayed monthly rate involves prepayment. The complete CoreAge Rx review examines the consultation and support questions. A simple headline can still require an individual quote and assessment.
PeterMD: the important distinction
The directly retrieved product page showed $211.65 for a four-week supply and $585 for twelve weeks. It also excluded Alabama and Idaho. The review did not verify a complete individual checkout total. This comes from the provider's official information and the additional sources linked in our review. The amount and service details should be confirmed for the actual prescription before payment.
The public pathway describes a health intake and video consultation after purchase, with medication dispatched only when approved. Ask what fees apply before the prescribing decision and what happens financially if no prescription is issued. Read the full PeterMD review for the limits of what we verified. The most useful question is: What is the full charge before the prescribing decision, and what is returned if treatment is not approved?
Compare the same financial commitment
Record the initial payment, period covered, next charge, medicine quantity, and separate clinical or membership fees. If a provider does not disclose an amount, retain it as an open question. It is not valid to treat an unknown charge as zero or invent a dosing schedule to turn a vial price into a monthly figure.
The cost guide and worksheet can organize the answers. Ask how a decision not to prescribe, a clinical reassessment, or a change in the plan affects future payments. A cheaper displayed number can be useful information without being a complete comparison of value.
Compare the assessment before the convenience
Ask each service who will review your history, which records or tests are needed, and what alternatives may be considered. If you already receive care for a complex condition, explain that relationship. Neither a quick intake nor a larger test panel proves that one service is clinically better for you.
The lab-testing guide helps connect tests with a purpose. The Endocrine Society guideline addresses adult growth hormone deficiency; it is not an endorsement of either provider or a universal reason for an adult to use sermorelin.
The product questions apply to both
Confirm the actual formulation, route, pharmacy, label, and supplied instructions if treatment is prescribed. Compounded drugs are not FDA-approved. A pharmacy's licensing and a provider's marketing language do not change that product distinction.
Read the pharmacy guide and safety guide. We do not infer identical preparations from a shared ingredient name, and we do not infer better outcomes from a commercial ranking. Ask what evidence applies to the exact use and preparation being discussed.
What could make either option a poor fit
The practical obstacles may be state availability, a required appointment format, the total commitment, or the need for a different kind of assessment. It is also possible that neither service's proposed treatment is appropriate. A consultation should leave room for that answer rather than make prescribing feel inevitable.
Several testimonials on the sermorelin page discuss GLP-1 treatment and weight loss. They are not evidence of outcomes from PeterMD sermorelin. CoreAge's treatment claims also need the same scrutiny. Our evidence guide explains why testimonials, biological mechanisms, and laboratory changes are not interchangeable with measured patient benefits.
A useful next step
Ask both providers for the same written information: the complete quote, clinical pathway, dispensing pharmacy, follow-up arrangements, and cancellation method. Keep the answers with their dates. Then discuss the clinical questions with the professional responsible for your care.
Use the consultation checklist, browse the provider directory, and compare the other side-by-side articles. The purpose is to make the open questions clear enough to resolve before a commitment, while keeping our commercial relationship visible.
Prepare the conversation around your own concerns
For this comparison, read sermorelin second opinion, sermorelin symptom diary. These guides address the decisions that can be missed when a comparison stops at the advertised medicine price.
The source notes
Sources & further reading
Provider pages document advertised offers, not independently proven outcomes. Historical references may concern different products or uses. Sources were checked for this edition on September 21, 2026; offers can change.